# Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage

> **NCT06753786** · NA · RECRUITING · sponsor: **Pirogov Russian National Research Medical University** · enrollment: 200 (estimated)

## Conditions studied

- Venous Thromboembolism
- Pulmonary Embolism
- Intracerebral Hemorrhage
- Deep Vein Thrombosis

## Interventions

- **DRUG:** Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the first 2 days but not earlier than 12 hours after a hospital admission.
- **DRUG:** Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting on the 3rd day after a hospital admission.

## Key facts

- **NCT ID:** NCT06753786
- **Lead sponsor:** Pirogov Russian National Research Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-21
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06753786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06753786, "Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06753786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*